WHO diabetes targets: accelerating progress towards 2030

Last update: 19/05/2022

Date: May 18, 13:00-14:30 CEST

WHO pre webinar landscape 01

The International Diabetes Federation (IDF) hosted an online event featuring a global panel of experts that looked at the potential of the WHO Global Diabetes Compact and the new WHO diabetes coverage targets to improve the lives of people living with diabetes.

Despite recent global efforts to tackle the diabetes pandemic, the number of people living with diabetes continues to rise – reaching 537 million in 2021. The projections are stark, with most countries off-track to achieve the WHO target of a 0% increase in diabetes prevalence by 2025.

To accelerate progress on diabetes and other NCDs, WHO has developed the Global Diabetes Compact with the vision of reducing the impact of diabetes and ensuring that all people with the condition have access to equitable, comprehensive, affordable and quality treatment and care. A core component of the Compact will be the new set of diabetes coverage targets that will be voted on at the 75th World Health Assembly (23-29 May, 2022).

  • Target 1: 80% of people with diabetes are diagnosed
  • Target 2: 80% of people diagnosed have a good control of glycaemia
  • Target 3: 80% of people diagnosed have a good control of blood pressure
  • Target 4: 60% of people with diabetes over 40 years or older receive statins
  • Target 5: 100% of people with type 1 diabetes have access to affordable insulin treatment and blood glucose self-monitoring

This online event was moderated by Ms Bridget McNulty, a diabetes advocate and IDF Blue Circle Voice from South Africa.

Speakers included:

  • Mrs Kazi Zebunnesa Begum, Additional Secretary (WH), HSD, Bangladesh Ministry of Health and Family Welfare
  • Prof Stephen Colagiuri, IDF Vice-president
  • Dr Bente Mikkelsen, Director, WHO NCDs department
  • Dr Slim Slama, Unit Head, WHO, NCD Management-Screening, Diagnosis and Treatment unit
  • Ms Leanne Riley, WHO, Head of the Surveillance, Monitoring and Reporting Unit, NCD department
  • Prof Edward Gregg, School of Public Health, Imperial College London
  • Prof João Raposo, Associação Protectora dos Diabéticos de Portugal
  • Ms Emma Klatman, Global Advocacy and Policy Manager, Life for a Child

Download the webinar agenda, the speaker biographies and the slides 

Access the recording below: 

If you have any questions about this webinar, please send them to This email address is being protected from spambots. You need JavaScript enabled to view it..

© 2022 International Diabetes Federation Disclaimer Privacy policy